Décard BF[au] - Search Results

Year	Number of Results
2010	1
2012	4
2013	2
2014	3
2015	7
2016	10
2017	6
2018	3
2019	5
2020	1
2021	2

1

PML with dimethyl fumarate-No convincing case against natalizumab.

Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J. Diebold M, et al. Among authors: decard bf. Mult Scler. 2019 Oct;25(12):1687-1688. doi: 10.1177/1352458519872894. Epub 2019 Aug 22. Mult Scler. 2019. PMID: 31436113 No abstract available.

2

Extensive bilateral brain lesions in neuromyelitis optica spectrum disorders.

Décard BF, Derfuss T. Décard BF, et al. Mult Scler. 2018 Aug;24(9):1262-1263. doi: 10.1177/1352458518771888. Epub 2018 Apr 20. Mult Scler. 2018. PMID: 29676200 No abstract available.

3

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment.

Diebold M, Fischer-Barnicol B, Tsagkas C, Kuhle J, Kappos L, Derfuss T, Décard BF. Diebold M, et al. Among authors: decard bf. Neurol Neuroimmunol Neuroinflamm. 2019 Jul 11;6(5):e594. doi: 10.1212/NXI.0000000000000594. Print 2019 Sep. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31454772 Free PMC article.

4

Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISH.

Streckmann F, Hess V, Bloch W, Décard BF, Ritzmann R, Lehmann HC, Balke M, Koliamitra C, Oschwald V, Elter T, Zahner L, Donath L, Roth R, Faude O. Streckmann F, et al. Among authors: decard bf. BMJ Open. 2019 Apr 24;9(4):e024467. doi: 10.1136/bmjopen-2018-024467. BMJ Open. 2019. PMID: 31023750 Free PMC article.

5

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.

Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J. Diebold M, et al. Among authors: decard bf. Mult Scler. 2019 Oct;25(12):1682-1685. doi: 10.1177/1352458519852100. Epub 2019 Jun 18. Mult Scler. 2019. PMID: 31208265

6

Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.

von Wyl V, Décard BF, Benkert P, Lorscheider J, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, Yaldizli Ö. von Wyl V, et al. Among authors: decard bf. Eur J Neurol. 2020 Jun;27(6):1066-1075. doi: 10.1111/ene.14191. Epub 2020 Apr 3. Eur J Neurol. 2020. PMID: 32097512

7

A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditions.

Diebold M, Müller S, Derfuss T, Décard BF. Diebold M, et al. Among authors: decard bf. Mult Scler Relat Disord. 2019 Jun;31:38-40. doi: 10.1016/j.msard.2019.03.009. Epub 2019 Mar 9. Mult Scler Relat Disord. 2019. PMID: 30901703

8

Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.

Décard BF, Derfuss T. Décard BF, et al. Semin Neurol. 2016 Apr;36(2):128-39. doi: 10.1055/s-0036-1580720. Epub 2016 Apr 26. Semin Neurol. 2016. PMID: 27116719 Review.

9

Nerve Hypertrophy in Primary Amyloidosis.

Rasenack M, Proebstel AK, Athanasopoulou IM, Décard BF, Grimm A. Rasenack M, et al. Among authors: decard bf. Muscle Nerve. 2016 Sep;54(3):510-2. doi: 10.1002/mus.25113. Epub 2016 Apr 28. Muscle Nerve. 2016. PMID: 26999802 No abstract available.

10

Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies - Current concepts and future directions.

Décard BF, Pham M, Grimm A. Décard BF, et al. Clin Neurophysiol. 2018 Jan;129(1):155-167. doi: 10.1016/j.clinph.2017.10.028. Epub 2017 Nov 10. Clin Neurophysiol. 2018. PMID: 29190522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results